Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Optimi Health Corp (CSE: OPTI )

0.3250 +0.0150 (+4.84%)
Streaming Delayed Price Updated: 9:52 AM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,193
Open 0.3300
Bid (Size) 0.3200 (500)
Ask (Size) 0.3250 (2,500)
Prev. Close 0.3100
Today's Range 0.3250 - 0.3300
52wk Range 0.1500 - 0.5800
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Early Warning Press Release in Accordance with National Instrument 62-103
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 110,000 common shares (each... 
Via Newsfile
Optimi Health Announces C$3.27 Million Private Placement with Strategic Investment from Lululemon Founder Chip Wilson
Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP-grade psilocybin, synthetic psychedelic substances and... 
Via PressReach

Performance

YTD
+14.04%
+14.04%
1 Month
-1.52%
-1.52%
3 Month
-2.99%
-2.99%
6 Month
-4.41%
-4.41%
1 Year
+71.05%
+71.05%

More News

Read More
Psychedelic Drugs Prove Their Worth In Clinical Trials
Via PressReach
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via PressReach
Topics Cannabis
Exposures Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA
Via PressReach
Topics Supply Chain
Exposures Supply Chain
Psychedelics May Make People Less Afraid of Death
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
Psychedelics Use Among Young Adults Reaches All-Time High
Via FinancialNewsMedia
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Rising Prevalence of Mental Depression & Anxiety Major Drivers Propelling Demand In Psychedelic Drugs Market
Via FinancialNewsMedia
Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market
Via FinancialNewsMedia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.